Biora Therapeutics (BIOR) Projected to Post Quarterly Earnings on Tuesday

Biora Therapeutics (NASDAQ:BIOR) is expected to announce its earnings results after the market closes on Tuesday, March 25th. Analysts expect the company to announce earnings of ($3.30) per share and revenue of $0.23 million for the quarter.

Biora Therapeutics Price Performance

Biora Therapeutics stock opened at $0.13 on Monday. The stock has a market capitalization of $589,799.20, a PE ratio of -0.01 and a beta of 1.12. The business has a 50 day simple moving average of $0.15 and a 200-day simple moving average of $2.07. Biora Therapeutics has a 12 month low of $0.15 and a 12 month high of $13.30.

About Biora Therapeutics

Biora Therapeutics, Inc, a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases.